SHEERY MARIE VILLAGRACIA: Open Payments
NPI 1275129868 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 14 payments from 11 companies in 2025. Trend: 2023 $500 · 2024 $148 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 2 | $177 |
| Travere Therapeutics, Inc. | 1 | $100 |
| ABIOMED | 1 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Calliditas Therapeutics US Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Tactile Systems Technology Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
Products named: Filspari, Kerendia, TARPEYO, Fabhalta, DUPIXENT, Flexitouch Plus, IBSRELA, TAVNEOS.
Industry payments across NV — which companies pay providers there.
